flecainide / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
flecainide / Generic mfg.
NCT00540787: A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

Completed
4
112
US, Europe
Radiofrequency ablation, antiarrhythmic drugs, Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs, ThermoCool Radiofrequency Catheter
Biosense Webster, Inc.
Paroxysmal Atrial Fibrillation
06/06
06/06
SARA, NCT00863213 / 2008-006095-30: Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

Completed
4
152
Europe
Atrial fibrillation ablation, Antiarrhythmic drug
Hospital Clinic of Barcelona, Medtronic, Fundacio Clinic Barcelona, Biosense Webster, Inc.
Atrial Fibrillation
03/11
12/12
CABAL, NCT01505296: Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

Withdrawn
4
0
US, RoW
Antiarrhythmic drug, Rhythmol, Tambocor, Betapace, Tikosyn, Catheter ablation, Thermocool
Valley Health System, Biosense Webster, Inc.
Atrial Fibrillation
01/14
01/14
FOREVER, NCT03587558: Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract

Unknown status
4
104
RoW
Carvedilol, Dilatrend, Flecainide, Tambocor
Keimyung University Dongsan Medical Center, Chong Kun Dang Pharmaceutical Corp.
Ventricular Premature Complexes, Outflow Tract, Carvedilol
12/19
12/20
EAST, NCT01288352 / 2010-021258-20: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial

Completed
4
2789
Europe, RoW
early standardised rhythm control
Atrial Fibrillation Network, Sanofi, Abbott, Deutsche Herzstiftung e.V., European Heart Rhythm Association (EHRA), BMBF (German Ministry for Science), Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Atrial Fibrillation, Stroke
03/20
05/20
NCT00408473 / 2006-003211-40: Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

Terminated
4
256
Europe
Flecainide
MEDA Pharma GmbH & Co. KG, 3M
Atrial Fibrillation
 
 
NCT00189319: To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Completed
4
200
Europe
Flecainide controlled release
MEDA Pharma GmbH & Co. KG
Atrial Fibrillation
 
 
NCT02347111: Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Recruiting
4
162
US
Flecainide, Sotalol
University of Illinois at Chicago, Medtronic
Atrial Fibrillation
06/25
06/25

Download Options